Brian Christian

Accreditations

Dr. Christian is a regulatory toxicologist with over 30 years of experience in the contract pharmaceutical research industry.  Prior to joining OSOD he served as the scientific lead for the ocular toxicology services offered at Covance/Labcorp Laboratories which included planning and directing nonclinical toxicology and pharmacology studies as senior study director.  Brian is a diplomate of the American Board of Toxicology and has served on the Executive Committee of the Ocular Toxicology Specialty Section of the Society of Toxicology.    

Recent Publications

2021

Semiquantitative Methods for GFP Immunohistochemistry and In Situ Hybridization to Evaluate AAV Transduction of Mouse Retinal Cells Following Subretinal Injection
Read Publication

2019

Normative Values for Multifocal ERGs Recorded from Cynomolgus Macaques in a Non-clinical Setting
Read Publication

2018

Ocular Safety of AAV2. 7m8-ChrimsonR-tdTomato (GS030-DP) following intravitreous injection and exposure to 595 nm LED light in blind rd1 mice
Read Publication

2017

Preliminary tolerability of iPSC-Derived RPE on PLGA scaffold implantation in RNU Nude Rats
Read Publication

2016

Variability in the Electroretinographic Response of Laboratory Animals
Read Publication

2015

Functional and Structural Effects of Subretinal Dose Delivery in Mice
Read Publication

2014

Gender Differences in Anesthetized Primate ERG and Full-field Flash VEP
Read Publication

2013

Emerging Imaging Technologies for Assessing Ocular Toxicity in Laboratory Animals
Read Publication
Inner Nuclear Layer (INL) Cystoid Spaces (Lacunae) Observed in Experimental Glaucoma and Axotomy in Non-Human Primates (NHPs)
Read Publication
Electrophysiologic Correlates of RNFL Thickness in Experimental Glaucoma
Read Publication

2011

Subretinal Administration of Fluorescent Microspheres in the Minipig
Read Publication
Safety And Tolerability Of Retinostat®, A Lentiviral-vector Based Gene Therapy Product For The Treatment Of Wet Age-related Macular Degeneration, In Rabbits And Monkeys
Read Publication
Inter-ocular And Inter-subject Variability In The Full-field Electroretinograms Of Rabbits And Monkeys
Read Publication

2010

Supplemental Clock-Hour Fluorescein Angiography (FA) Scoring and Image Analysis of Laser-Induced Choroidal Neovascularization (CNV) Lesions in Cynomolgus Monkeys
Read Publication
INO-8875, an adenosine A1 agonist, lowers intraocular pressure through the conventional outflow pathway
Read Publication
Spectral domain OCT segmentation accuracy in monkeys
Read Publication

2009

Bilateral optic atrophy: a background finding in cynomolgus macaques used in toxicologic research
Read Publication
Continuous Monitoring of Intraocular Pressure in New Zealand White Rabbits Using Telemetry
Read Publication
Ocular inflammation in cynomolgus macaques following intravenous administration of a human monoclonal antibody
Read Publication

2008

Evaluation of EIAV Based Lentiviral Vectors Following Ocular Delivery in the Nonhuman Primate Model: Development of RetinoStat®
Read Publication
Pachymetry in New Zealand White Rabbits, Beagle Dogs, and Cynomolgus Monkeys.
Read Publication
Corneal endothelial cell density measurements using noncontact specular microscopy in rabbits, dogs and monkeys
Read Publication
Standardized Full-Field Electroretinography in Cynomolgus Monkeys
Read Publication

2006

Safety evaluation of intravitreal administration of VEGF trap in cynomolgus monkeys for 13 weeks.
Read Publication

2003

Characterization of a Monkey Model of Laser-Induced Choroidal Neovascularization (CNV)
Read Publication
26-Week Intravitreal Injection Toxicity Study with rhuFab VEGF in Cynomolgus Monkeys with an 8-Week Recovery
Read Publication

2001

Safety Evaluation of Differing Schedules of Intravitreal Administration of rhuFab VEGF in Cynomolgus Monkeys for 2 Months
Read Publication

2000

Safety Evaluation of Intravitreal Administration of rhuFab VEGF in Cynomolgus Monkeys for 3 Months
Read Publication